Akamai (AKAM) Wins Appeal in Content Delivery Patent Case vs. Limelight (LLNW)
1:26 PM ET, 08/31/2012 - Street Insider
Shares of Limelight Networks (Nasdaq: LLNW) are trickling lower Friday following reporst that it is facing another round of patent litigation from peer Akamai Technologies (Nasdaq: AKAM).
According to Bloomberg, Akamai's case against Limelight was revived by the U.S. Court of Appeals for the Federal Circuit in Washington.
Akamai's claim is to online content delivery of doctor and patient communication. Currently, Limelight says it hasn't infringed on a patent unless all steps are followed. The company is being backed up by names like Apple (Nasdaq: AAPL) and Google (Nasdaq: GOOG), while pharma's like Bristol-Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE) say infinging the patent would affect patient rights.
Limelight Networks, Inc. (LLNW), a leader in Digital Presence Management, today released the following comment regarding today's Court of Appeals for the Federal Circuit en bank opinion in the ongoing litigation with Akamai.
"Today's Court of Appeals for the Federal Circuit en bank opinion in the ongoing litigation with Akamai does not substantiate Akamai's claims that Limelight infringes Akamai's patents, nor does it mean that Limelight owes any damages to Akamai. The Court's decision effectively sets aside the jury's original verdict. Under the new inducement theory articulated by the en bank Court, Limelight continues to believe it does not infringe and will pursue all procedural avenues to vindication."